Qualitative examination of the subjective experience of intravenous psilocybin in an MRI environment .
A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment
Curr Drug Abuse Rev. 2014 11-Apr;():. 10.2174/1874473708666150107120930Fifteen healthy psychedelic experienced participants were administered an intravenous dose of either placebo or 2 mg of psilocybin on two different testing days in an fMRI scanner to determine the subjective experience. Patients participated in an interview and also answered a battery of visual analog scale items on subjective psychological effects of the drugs. Patients reported perceptual changes, cognitive changes, changes in mood, effects on memory, spiritual experiences, changes to their environment, comparisons with other experience, intensity and onset of effects, an interpretation of the experience.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
